Wellington Management

Wellington Management Company is a Boston based institutional investment advisor firm. The firm invests in global equity, fixed income, currency and commodity markets, multi-strategy, specialty and alternative investments. The firm offers separate accounts and a wide range of commingled vehicles that include both US and non-US domiciled portfolios. The company was founded in 1928.

Pamela Choney

Partner and SVP

CD

Cheryl Duckworth

Partner

PE

Patrick Eastwood

Director Client Integration and Administration and MD

AM

Anita M. Killian

Director, Partner, VP, Global Industry Analyst and Portfolio Manager

AK

Adele Kohler

Director, Alternative Investment Solutions

MC

Mandel C.F.A., CFA, Mark D.

Portfolio Manager

DS

Danny Sharp

Director, Midwest Region and Business Development Manager

ES

Edward Steinborn

CFO

AS

Anji Stewart

Director and Head of EMEA Marketing

Brendan Swords

Chairman and CEO

Matthew Witheiler

MD

Past deals in Banks

Current

Series D in 2021
Current is a leading U.S. challenger bank built to meet the needs of people with unique lives who have been overlooked by the traditional banking industry. Our proprietary Current Core technology allows us to provide premium banking services for everyone, regardless of age or income, and improve the financial outcomes of our members without overdraft fees, minimum balance requirements, or hidden fees. We give members up to two days faster direct deposit paychecks, free overdrafts up to $100 with Overdrive™ , points on purchases redeemable for cash back, access to 55,000 free ATMs worldwide as well as 24/7 member support 365 days a year.

Latch

Post in 2021
Latch makes access easier for everyone at a modern building. The company specializes in manufacturing keyless entry security system giving property owners the ability to manage every door in a multi-family building. Moreover, residents can also give access to guests as well as service providers through time-limited access codes. Latch is headquartered in New York, New York, United States.

CytomX Therapeutics, Inc.

Series D in 2015
CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodiesâ„¢, proteolytically-activated antibodies. Probodies, by their ability to site-direct the activity of antibodies, will result in an improved therapeutic index for validated targets as well enable the drugging of targets with broad tissue expression. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.

Porch.com, Inc.

Post in 2020
Porch.com, Inc. operates an online platform that connects homeowners with local home repair services. The company also facilitates customers to arrange set-up and installation for purchased goods through overstock e-commerce platform. In addition, it offers Service Attach, a tool that enables overstock customers to add installation or assembly services to online shopping carts. Porch.com, Inc. has a strategic partnership with Cinch Home Services Inc. The company as incorporated in 2011 and is based in Seattle, Washington.

Payfone

Series H in 2020
Payfone provides businesses with Identity Certainty - the ability to confirm that their customers are who they say they are to create easy, secure and frictionless experiences across PCs, mobile phones and tablets. They do for digital security what Uber does for hailing taxis and what Amazon does for online shopping. They make authenticating your customers easy for you and effortless for them. They're backed by leading banks, venture firms and wireless carriers, and are based in New York City.

Vets First Choice

Venture Round in 2017
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.

BetterUp Inc.

Series E in 2021
Founded in 2013, BetterUp is a mobile-based leadership development platform used by Fortune 500 companies. With a holistic, science-backed methodology, BetterUp develops new behaviors and mindsets that enable high performance amid constant and accelerating change. Through on-demand, virtual coaching sessions, users practice and reinforce new behaviors and skills. Individual growth is measured and tracked. With a diverse range of customers, including Genentech, Logitech, and Workday, BetterUp inspires employees to build the skills to thrive personally and professionally.

Patreon

Series F in 2021
Patreon Inc. operates a platform for enabling content creators and artists to be able to fund their work. It offers Patreon.com, a communications platform for enabling connections between users and makes them accessible various content, including videos, photographs, images, artwork, graphics, audio clips, comments, data, text, software, scripts, projects, other material and information, and associated trademarks and copyrightable works. The company was founded in 2013 and is based in San Francisco, California.

Speakaboos

Series B in 2016
BEGiN is the award-winning education technology company that creates engaging and effective learning products to bring the highest quality education to young children everywhere. Their library of interactive stories helps their child fall in love with reading while building critical skills. BEGiN’s investors and partners include some of the most recognized and well-loved children’s brands including Sesame Workshop, LEGO Ventures, Gymboree Play and Music, and Fisher-Price. BEGiN was co-founded by Neal Shenoy, Noelle Millholt, and Stephanie Dua and is one of Crain’s 100 Best Places to Work in New York City.

Scale

Series E in 2021
Scale accelerates the development of AI applications by helping machine learning teams generate high-quality ground truth data. Our advanced LiDAR, video, and image annotation APIs allow self-driving, drone, and robotics teams at companies like Lyft, OpenAI, Zoox, Pinterest, and Airbnb focus on building differentiated models vs. labeling data.

Peloton Interactive, Inc.

Series F in 2018
Peloton is revolutionizing the fitness industry by merging high-design with modern technology to provide access to live and on-demand fitness group classes led by elite NYC instructors. With instant access to classes, performance tracking metrics and a motivating real-time leaderboard, Peloton is changing the way people get fit through a comprehensive and socially connected-experience that makes every workout both efficient and addicting. By merging hardware, software, and content, Peloton creates the most unique, efficient and addicting workout experience on the market. Peloton is sold online and in their growing number of showrooms across the country.

GreenSky

Venture Round in 2014
GreenSky, Inc., a technology company, provides point-of-sale financing and payment solutions to merchants, consumers, and banks. It offers a proprietary technology infrastructure that supports the full transaction lifecycle, including credit application, underwriting, real-time allocation to bank partners, document distribution, funding, settlement, and servicing functions. The company was founded in 2006 and is headquartered in Atlanta, Georgia.

EVgo

Post in 2021
EVgo Services LLC owns and operates network of fast chargers for electric vehicles. It operates charging stations compatible with all fast charge capable electric vehicle models. The company was incorporated in 2010 and is based in Los Angeles, California.

Oxford Nanopore Technologies

Venture Round in 2021
Oxford Nanopore Technologies Limited develops and commercializes nanopore-based electronic systems for analysis of single molecules. The company offers MinION, a portable device for molecular analysis based on nanopore technology and is adaptable for the analysis of DNA, RNA, proteins, and small molecules; MinIT, an analysis and device control accessory for nanopore DNA sequencing; PromethION, a tablet-sized benchtop instrument that provides real-time data streaming; GridION system for molecular sensing applications; 109 cDNA Kits for its real-time and scalable sequencing technology that provides high throughput whilst generating complete sequences of full-length cDNA strands; and Flongle, a paradigm of smaller on-demand DNA or RNA sequencing tests with the potential to transform a range of applications where insights are required at low cost. Its devices are used in scientific research, personalized medicine, crop science, and security and defense applications. The company sells its products online. Oxford Nanopore Technologies Limited was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. The company was incorporated in 2005 and is based in Oxford, United Kingdom with additional offices in the United Kingdom, the United States, China, Japan, Germany, France, India, and Singapore.

Aligos Therapeutics

Series B in 2020
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.

Digit Insurance

Venture Round in 2022
Digit is a new-age general insurance company started by Kamesh Goyal and backed by the Fairfax Group, one of the largest financial services groups in the world. The company has raised two rounds of funding amounting to $140 million from Canadian billionaire Prem Watsa’s Fairfax Holdings, which is one of the largest insurance investment companies in the world with operations in over 30 countries. Headquartered in Bengaluru, Digit has successfully partnered with some of the leading companies. Digit Insurance has featured in the Top 25 Indian Startups Lists by Linkedin in 2018 and 2019 and was featured in CB Insights’ top 250 fastest-growing fintech companies globally in 2018.

SensAble Technologies

Series C in 2000
SensAble Technologies, Inc. offers force-feedback haptic devices and touch-enabled 3D modeling software solutions. Its products include FreeForm Modeling Systems, which are 3D touch-enabled systems for medical and dental modeling, product design, digital content creation, and fine arts; and The SensAble Dental Lab System, a digital system for scanning, 3D modeling and design, and 3D fabrication. The company also provides PHANTOM Haptic Devices, which deliver force feedback, 3D navigation, and virtual workspaces; and OpenHaptics, a software development toolkit for developing haptic applications. In addition, it offers 3D touch-enabled modeling systems, software and devices, and 3D modeling software, and sculptural modeling for digital content creation and fine arts. SensAble Technologies serves academic/education, automotive/motorcycle, ceramics, characters and creatures, collectibles/giftware, confectionary, consumer products, dental, engraving, relief and flatware, facial reconstruction, film and video, fine arts and sculpture, footwear, games, home decor and housewares, jewelry, medical, packaging, personal care products, sporting goods, tooling, toys and promotional, assembly path planning, molecular modeling, simulation and visualization, and training industries. The company's products are used in product design, medical and dental modeling, digital content creation, fine arts applications, surgical simulation and stroke rehabilitation, dental restorations, and research and robotic applications. It offers its products through inside sales channels and resellers. The company was founded as SensAble Devices, Inc. in 1993 and changed its name to SensAble Technologies, Inc. in 1996. SensAble Technologies, Inc. is based in Woburn, Massachusetts with a sales office in Tokyo, Japan.

Magic Leap

Series C in 2016
Magic Leap is a proprietary wearable technology that enables users to interact with digital devices in a completely visually cinematic way. Magic Leap is an Augmented Reality US-based startup that is innovating in the AR space to create new hardware and software that will give its users a never-before-seen AR experience and redefine how we access screens and visualize data. The headset combines a user's inherent visual ability with mobile computing – giving visual output equivalent to real-world experience but powered by mobile tech. Using their Dynamic Digitized Lightfield Signal, they generate images indistinguishable from real objects and place those images seamlessly into the real world.

Current

Series B in 2019
Current is a leading U.S. challenger bank built to meet the needs of people with unique lives who have been overlooked by the traditional banking industry. Our proprietary Current Core technology allows us to provide premium banking services for everyone, regardless of age or income, and improve the financial outcomes of our members without overdraft fees, minimum balance requirements, or hidden fees. We give members up to two days faster direct deposit paychecks, free overdrafts up to $100 with Overdrive™ , points on purchases redeemable for cash back, access to 55,000 free ATMs worldwide as well as 24/7 member support 365 days a year.

Adaptimmune

Series A in 2014
Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroys cancerous or infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was incorporated in 2007 and is based in Abingdon, United Kingdom.

Cityblock Health, Inc.

Series C in 2020
Cityblock Health, Inc. develops an online platform that offers primary care, behavioral health, and virtual care services for lower-income communities. Its solutions enable low-income urban residents to get personalized care, including preventive visits, mental health coverage, and access to appropriate social service programs. It offers Commons, a tool for communications, information sharing, and managing tasks. Cityblock Health, Inc. was incorporated in 2017 and is based in Brooklyn, New York.

Skillz

Post in 2020
Skillz, the leading mobile eSports platform, connects the world’s 2.6 billion mobile gamers through competition. In 2017, Skillz was named the #1 fastest-growing private company in America by Inc. Magazine, the first eSports company on CNBC’s Disruptor 50, and the only eSports company on the San Francisco Business Times Fast 100. Over 18 million gamers use Skillz to compete in mobile games across 13,000+ game studios. Founded in 2012, Skillz is headquartered in San Francisco and backed by leading venture capitalists as well as the owners of the New England Patriots, Milwaukee Bucks, New York Mets and Sacramento Kings. To learn more, visit www.skillz.com.

Swiggy

Series H in 2018
Swiggy provides a complete food ordering and delivery solution from the best neighborhood restaurants to the urban foodie. Swiggy aims to stand out by offering a more curated list of restaurants and services, not to mention its own in-house delivery fleet that pick up orders from restaurants and deliver it to the customers. It charges between 15-40 percent in commission to restaurants and for smaller orders, customers pay an additional delivery charge between 20 and 50 rupees depending on their city. Currently, Swiggy is in eight cities where it has more than 9,000 restaurants on its platform.

Kymera Therapeutics

Series C in 2020
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.

ezCater

Series D in 2019
ezCater, Inc. provides online catering ordering solutions for small start-ups and Fortune 500 companies. Its solutions enable users to order food online for meetings. The company offers ezManage, a catering management platform; and ezOrdering that provides restaurants with means to accept online catering orders on their own website. ezCater, Inc. was founded in 2007 and is based in Boston, Massachusetts. It has an additional office in Denver, Colorado.

Nutanix Beam

Series E in 2014
Nutanix Beam provides Beam, a multi-cloud optimization service that is delivered as part of the Nutanix Enterprise Cloud OS. Its Beam provides organizations with deep visibility and rich analytics detailing cloud consumption patterns, along with one-click cost optimization across cloud environments. The company’s Beam identifies idle and underutilized resources, and delivers specific recommendations to right-size infrastructure services and ensure optimal consumption, as well as automates security compliance with continuous monitoring of health checks and security best practices. Nutanix Beam was formerly known as Botmetric, LLC. The company was founded in 2014 and is headquartered in Santa Clara, California.
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

PMV Pharmaceutcals

Series D in 2020
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Wish

Corporate Round in 2017
Founded in 2010 and headquartered in San Francisco, Wish is an e-commerce platform, putting a digital shopping mall of affordable goods directly in the pockets of consumers worldwide. Wish employs big data principles, machine-learning, and search technologies to create a highly-visual, entertaining, and personalized browsing experience for each user. The company leverages a global network of direct suppliers, providing access to top quality, affordable products to anyone with a smartphone. As of 2018, Wish has more than 80 million monthly active users, over one million merchants, and sells nearly 1 billion products annually. For more information about the company or to download the Wish mobile app.

Saluda Medical

Venture Round in 2023
Saluda Medical Pty Ltd., a medical device company, develops Evoke, an investigational device for the neuromodulation industry worldwide. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. Saluda Medical Pty Ltd. was incorporated in 2010 and is headquartered in Artarmon, Australia with additional offices in Bloomington, Minnesota; and Harrogate; United Kingdom.

Tanium

Private Equity Round in 2018
Tanium is a security and systems management platform that allows real-time data collection at an enterprise scale. It provides enterprise and government organizations with tools to secure, control, and manage millions of endpoints across the enterprise within seconds. The platform allows security and IT operations teams to get access to visibility and accurate information on the state of endpoints at all times to protect against modern-day disruptions and realize new levels of business resilience. Tanium was founded by David Hindawi and Orion Hindawi in 2007 and is headquartered in Kirkland, Washington, United States.

Asher Bio

Series B in 2021
Asher Bio is an information technology company that specializes in the fields of CFO Office transformation, profitability, and cost management. It focuses on building and developing better immunotherapy for cancer. The company was founded in 2019 and headquartered in San Francisco, California.

Guild Education

Series F in 2022
Guild Education's lifelong learning platform offers classes, programs and degrees for working adults, with a path for them to move forward in their education and career. Guild offers these adults support from start to finish, with their technology platform for discovery, learning, and organizing the experience, and extra support with their tech-enabled student advising model. Founded in 2015, the company is headquartered in Denver, Colorado, United States.

SpotOn

Series E in 2021
SpotOn is a payments and software company redefining the merchant services industry. The company brings together payment processing and customer engagement software, giving merchants richer data and tools that empower them to market more effectively to their customers. Its platform offers tools for small and medium businesses, including payments, marketing, reviews, analytics, and loyalty, backed by industry-leading customer care. Doron Friedman, Matt Hyman, and Zach Hyman co-founded SpotOn in 2017 and its headquarters is located in San Francisco, California.

Acrivon Therapeutics

Series B in 2021
Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success.

Affinivax

Series C in 2021
Affinivax, Inc., a biotechnology company, focuses on developing multiple antigen presenting system (MAPS) technology based vaccines that provide protection against various infectious diseases afflicting children and adults around the globe. Its MAPS enables the binding of protective polysaccharides and proteins in a single vaccine and induces a protective immune response. The company develops its vaccine programs to target various pathogens, such as streptococcus pneumoniae (pneumococcus), bacterial nosocomial infections, salmonella typhi, and staphylococcus aureus. Affinivax, Inc. was incorporated in 2014 and is based in Lexington, Massachusetts.

Fuze

Series E in 2017
Fuze Digital Solutions, LLC designs and develops Web based social business software Fuze Suite which builds and maintains customer loyalty by customer care, communication, and collaboration. The software comprises community knowledge base, case management, chat, feedback management, contact management, Fuze Social and online reporting. Its clientele include Careerbuilder.com, Fujitsu, Sutherland Group, SonicWALL, Oregon Health & Sciences University, and AAA clubs. Fuze Digital Solutions, LLC was founded in 2002 and is based in Bellevue, Washington.

AMP Robotics Corporation

Series C in 2023
AMP Robotics Corporation designs and manufactures robotic systems for material recovery facilities and recycling businesses that automates the identification, sorting, and processing of complex waste streams. It offers AMP Cortex that picks and sorts recyclable materials while reducing sorting costs; AMP Neuron, a software solution that captures the material on the recycling lines as valuable data to distinguish features in much the same way as the human eye; and hosted solutions. AMP Robotics Corporation was formerly known as Cognitive Robotics, LLC. AMP Robotics Corporation has a strategic partnership with First Star Recycling. The company was incorporated in 2014 and is based in Louisville, Colorado.

Olist

Series E in 2021
Olist operates an online e-commerce site for sellers, that connects merchants and their products to the main marketplaces of Brazil. It has developed a platform for shopkeepers of all sizes and segments to register their products to be sold at the Olist store within Brazil's top retailers. The company connects to the structuring of a solid business and focuses on the excellence of services provided to tenants and end consumers. It invests in a sustainable and fair business model for all involved. Olist was founded in 2015 and is based in Curitiba, Brazil.

Last Brand

Series B in 2023
Quince is a new e-commerce company that focuses on leveraging an M2C supply chain to deliver premium essentials at the lowest market price. It acts as a thin storefront to bring manufacturers and artisans closer to their customers through shared partnership in brand or marketing. The company was founded in 2018 and is headquartered in San Francisco, California.

Boundless Bio, Inc.

Series C in 2023
Boundless Bio, Inc., biopharma company, develops therapies and medicines for the treatment of cancers. It offers therapeutics based on extrachromosomal DNA (ecDNA) one of the drivers of the aggressive cancers, such as cancers characterized by high copy number amplification of oncogenes. The company was formerly known as Pretzel Therapeutics, Inc. Boundless Bio, Inc. was founded in 2018 and is based in LA Jolla, California.

Payoneer

Post in 2021
Payoneer empowers global commerce by connecting businesses, professionals, countries and currencies with its innovative cross-border payments platform. In today's borderless digital world, Payoneer enables millions of businesses and professionals from more than 200 countries to reach new audiences by facilitating seamless, cross-border payments. Additionally, thousands of leading corporations including Google, Airbnb, Elance-oDesk and Getty Images rely on Payoneer's mass payout services. With Payoneer's fast, flexible, secure and low-cost solutions, businesses and professionals in both developed and emerging markets can now pay and get paid globally as easily as they do locally. Founded in 2005 and based in New York, Payoneer is venture-backed, profitable and ranked in the top 100 of Inc. 5000's Financial Services companies.

Somatus, Inc.

Series E in 2022
Somatus is a healthcare company that partners with health plans, health systems, and nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' is vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease.

Billtrust, Inc.

Post in 2021
Billtrust develops a payment cycle management platform designed to automate every step in the invoice-to-cash process. Its platform accelerates cash flow by automating invoice delivery, invoice payment, and cash application for remarkable cost savings, ease-of-use, and improved customer satisfaction rates, enabling businesses and corporate clients to improve operational efficiency. The company was founded in 2001 and is headquartered in Lawrenceville, New Jersey.

Arrival Limited

Post in 2021
Arrival is a technology company that develops a generation of two electric vehicles. It develops software, materials, components, and scalable skateboard platforms and its micro-factories allow them to make vehicles and adapt to any mobility ecosystem. It is a zero-emission solution for cities and a human-centered, intelligent design to revitalize public transportation. The company’s new method uses low CapEx, rapidly scalable Microfactories that can be placed anywhere in the world to serve the regions they are located in. It was founded in 2015 and is headquartered in London, England.

CodeSee

Seed Round in 2022
CodeSee analyzes the data flowing through your system to maintain an updated map of your system architecture, its components, and the connections between them. Developers can explore at a high level, or dive in and see the data right next to the code. In other words...We make grokking a codebase easy. Developers stop feeling like outsiders and start feeling like high performers. Faster.

Pure Storage, Inc.

Secondary Market in 2014
Pure Storage is pioneering a new class of enterprise storage that has been designed from the ground up to take full advantage of flash memory. The company's products accelerate random I/O-intensive applications like server virtualization, desktop virtualization (VDI), database (OLTP, rich analytics/OLAP, SQL, NoSQL), and cloud computing. Pure Storage makes it cost effective to broadly deploy flash within the data center, enabling organizations to manage growth within existing power and space constraints. Launching later this year, the company's products are in private beta with select customers. Pure Storage is funded by Greylock Partners and Sutter Hill Ventures.

Archaea Energy, LLC

Post in 2021
Archaea Energy is an emerging leader in developing renewable natural gas (“RNG”) which is a sustainable decarbonizing solution for high-carbon emission processes and industries that are impossible or inefficient to electrify.

NiKang Therapeutics, Inc.

Series C in 2021
NiKang Therapeutics is an early-stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Its discovery approach is informed by target structure biology and capitalizes on structure-based drug design enabling a rapid and efficient discovery and development of proprietary drug candidates with the most desirable pharmacological features into clinical studies.

Creditas

Series F in 2022
Creditas is a financial technology company, operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.
Perella Weinberg Partners is an independent, privately-owned financial services firm that provides corporate advisory and asset management services to clients around the world. The Firm has assembled a group of talented and experienced professionals recruited from a wide variety of leading global financial institutions. Launched in 2006, the company is divided into two business units: corporate advisory, which provides services to decision makers in business and government, and asset management, which consists of investment vehicles catering to institutional investors.

Warby Parker

Series D in 2015
Warby Parker is a lifestyle brand that offers designer eyewear at a revolutionary price operating as a socially conscious business. Approximately one billion people don't have access to affordable glasses. Glasses can increase one's income by 20%, enable students to see a blackboard, and offer dignity to those with poor eyesight. Warby Parker works with experienced non-profit partners to ensure that each sale of our frames will give someone in need access to affordable glasses.

Dave Inc.

Post in 2022
Dave Inc. develops an application that alerts users on their bank overdraft information. It offers Dave, a mobile application that helps users to predict their expenses and alert them to outsmart overdrafts; and prevent a low balance by unlocking the next paycheck. The company’s application also enables users to get advances on their paycheck and pay back when they get paid. Its application is available on App Store and Google Play. Dave Inc. was formerly known as Lending Labs Inc. Dave Inc. was founded in 2015 and is based in Los Angeles, California.

FalconX, Ltd.

Series D in 2022
FalconX is a digital asset trading platform that uses data science to provide clients with best execution capabilities. Over the last 10 months, the company has generated $7 billion in global trading volume at a quarterly growth rate of over 600%. Clients include over 100 financial institutions across traditional finance including hedge funds, proprietary trading firms, payment gateways, over-the-counter trading desks, cryptocurrency miners, and exchanges.

Emergy Foods

Series C in 2022
Meati Foods is a consumer goods company that offers carbon materials, bioengineering, and filtration. It focuses on using proprietary, clean technologies to provide nutrient-dense, plant-based meat alternatives that everyone can enjoy and feel good about eating every day.

Atreca

Series C in 2018
Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.

Butterfly Network

Post in 2021
Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. Jonathan M. Rothberg, Nevada Sanchez, and Tyler S. Ralston founded it in 2011, with its headquarters in Guilford in Connecticut.

Impulse Dynamics

Series D in 2019
Impulse Dynamics N.V., a medical device company, develops electrical therapies for the treatment of chronic heart failure in the United States and Europe. The company offers clinical trials, which are designed to evaluate the safety and efficacy of cardiac contractility modulation therapy, as well as performs research programs in universities and hospitals. It also provides Optimizer III that delivers non-excitatory electrical impulses to the ventricular septum during the myocardial absolute refractory period. It serves healthcare providers. Impulse Dynamics N.V. was founded in 1996 and is based in Willemstad, Curacao. It has an additional office in New York, as well as a sales and support office in Hong Kong. It operates product development centers in New Jersey and Israel.

Rubicon Global

Series C in 2015
Rubicon is a software company that provides smart waste and recycling solutions for businesses and governments worldwide. Using technology to drive environmental innovation, the company helps turn businesses into more sustainable enterprises, and neighborhoods into greener and smarter places to live and work. Rubicon’s mission is to end waste by helping its partners find economic value in their waste streams and confidently execute on their sustainability goals. Learn more at www.rubicon.com.

Moving Analytics

Series A in 2022
Moving Analytics. is a tele-health company dedicated to helping people thrive after heart disease. Our flagship product is Movn a virtual cardiac rehabilitation program that leverages evidence based guidelines, behavioral science, remote monitoring and personalized coaching to help patients recover to full health after a cardiac event. Movn is currently used by the Veterans Affairs Medical Center, Highmark Health Plan, Kaiser Permanente Northwest and many more health systems across the US.

UrbanClap

Series F in 2021
Urban Company (Formerly UrbanClap) was launched in Nov 2014. It is the largest home services platform in Asia, with presence in India, UAE, Singapore and Australia. The platform helps customers book reliable home services like beauty services, massage therapy, cleaning, plumbing, carpentry, appliance repair, painting etc. The company's vision is to empower millions of service professionals across the world to deliver services at home like never seen before. The company partners with tens of thousands of service professionals, helping them with with training, credit, product procurement, insurance, technology etc.

Arcadia, Inc.

Series D in 2021
Arcadia, Inc. operates an online platform for users to manage their account, track their account activity, and view their energy usage. It serves houses, apartments, and businesses in the United States. The company was formerly known as Arcadia Power, Inc. Arcadia, Inc. was incorporated in 2013 and is based in Washington, District Of Columbia.

Synthego

Series E in 2022
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs. By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology. The company was founded in 2012 and is based in Redwood City, California.

SoFi

Series E in 2015
SoFi is a finance company that offers a range of lending and wealth management services. The company primarily caters to early-stage professionals and offers variable and fixed rate parent, personal, and MBA loans, mortgage refinancing, and more. They create modern financial products and services that help people borrow, save, spend, invest, and protect their money better so that they can achieve financial independence and realize their ambitions from owning a home to saving for retirement, paying off their student loans, and more. It was founded in 2016 and is headquartered in San Francisco, California.

Sundae

Series C in 2021
Sundae’s mission is to help homeowners get the best outcome when it’s time to sell a house that needs some love. For too long, the process of selling outdated and damaged houses has been terrible for sellers. Local property investors capitalize on homeowner distress to purchase houses cheaply and resell them for huge profits. Sundae is putting more of those profits back in the hands of the homeowner. We’ve developed a model to predict when sellers will need our help, and a best-in-class sales and marketing team to reach them and a trusted brand that allows us to grow even faster through word of mouth and referrals. With scale and efficiency, we’re able to redistribute economic value to sellers in the form of the most competitive price so that Sundae can become the largest buyer of homes that need love in the United States.

Birst, Inc.

Series F in 2015
Birst is the world’s most advanced networked business analytics platform. Organizations can now achieve a new level of trusted insight and decision making by connecting their data and people via a network of analytics services. Birst scales from individuals to the enterprise in a manner that is smarter, more connected, and more scalable than any previous analytics and business intelligence platform. Learn more at www.birst.com and join the conversation @BirstBI.

Boundless Bio, Inc.

Series B in 2021
Boundless Bio, Inc., biopharma company, develops therapies and medicines for the treatment of cancers. It offers therapeutics based on extrachromosomal DNA (ecDNA) one of the drivers of the aggressive cancers, such as cancers characterized by high copy number amplification of oncogenes. The company was formerly known as Pretzel Therapeutics, Inc. Boundless Bio, Inc. was founded in 2018 and is based in LA Jolla, California.

Cityblock Health, Inc.

Series C in 2021
Cityblock Health, Inc. develops an online platform that offers primary care, behavioral health, and virtual care services for lower-income communities. Its solutions enable low-income urban residents to get personalized care, including preventive visits, mental health coverage, and access to appropriate social service programs. It offers Commons, a tool for communications, information sharing, and managing tasks. Cityblock Health, Inc. was incorporated in 2017 and is based in Brooklyn, New York.

Apigee

Venture Round in 2014
Apigee is a provider of API technology and services for enterprises and developers. The platform gives enterprises control over and visibility into the APIs that connect applications and data, across the enterprise and across clouds. Hundreds of companies including Walgreens, Bechtel, eBay, Pearson, and Gilt Groupe as well as tens of thousands of developers use Apigee to simplify the delivery, management and analysis of APIs and apps. Apigee's global headquarters are in Palo Alto, California, and it also has offices in Bangalore, India; London; and Austin, Texas.

Defy Media, Inc.

Series B in 2016
It’s the union of Alloy Digital and Break Media – two industry leaders that have created influential and culturally significant entertainment properties for 13-34 year old consumers. We own and operate some of the biggest brands and the most popular programming in digital media. Our capabilities in production, distribution, marketing and promotion have enabled us to build a powerful bond with our audience across all of the media platforms that matter most to them.

WeWork India

Series D in 2014
The We Company is a platform for creators that transforms buildings into dynamic environments for creativity, focus, and collaboration. The company transform buildings into beautiful, collaborative workspaces and provide infrastructure, services, events, and tech so their members can focus on doing what they love. The We Company is formerly known as "WeWork". It was established in 2018 and is headquartered in New York.

Lendbuzz

Series C in 2021
Lendbuzz Funding, LLC offers car loans to expats and international students. The company does not require Social Security Number (SSN) and provides loans to all visa holders from all nationalities. Its customers include students, international professionals, and other young professionals that have an international credit file. The company provides access and manages its loans through an online platform and data-intensive scoring technology. Lendbuzz Funding, LLC was founded in 2015 and is based in Boston, Massachusetts.

Arcadia, Inc.

Series E in 2022
Arcadia, Inc. operates an online platform for users to manage their account, track their account activity, and view their energy usage. It serves houses, apartments, and businesses in the United States. The company was formerly known as Arcadia Power, Inc. Arcadia, Inc. was incorporated in 2013 and is based in Washington, District Of Columbia.

Moderna Therapeutics

Series E in 2015
Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies inside patient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.

Anchorage

Series D in 2021
Anchorage is the first crypto-native Qualified Custodian for institutional investors, offering a comprehensive platform complete with trading, staking, and governance. Co-founded by security engineers from Square and Docker, Anchorage has raised $57 million in funding from such leading investors as Visa and Andreessen Horowitz, and counts as clients many of crypto’s largest and best-known funds, including Blockchain Capital, BlockTower, Polychain, and Paradigm. It was founded in 2017 and is headquartered in San Francisco, California.

Auris Health, Inc.

Series E in 2018
Auris Surgical Robotics is a company that provides robotic medical care that is transforming medical intervention by introducing the monarch platform. Auris aims to leverage the power of flexible robotics to enable new possibilities in endoscopy, which uses small cameras and tools to enter the body through its natural openings. The Monarch Platform integrates the latest advancements in imaging technology, robotics, endoscope design, sensing, and data science for better outcomes and reduced costs.

Span.IO

Series B in 2022
Span.IO, Inc. develops and supplies renewable energy products for homes. It offers smart electrical panels that replace the electrical panel to become the center for connected power in the homes. The company also provides The Span, an application that enables users to understand and control their home energy from anywhere and at any time; and is used for scheduling and get alerts. It serves homeowners through installers, technology providers, and energy companies. Span.IO, Inc. was founded in 2018 and is headquartered in San Francisco, California.

Course Hero, Inc.

Series C in 2021
Course Hero is an online learning platform with study resources that help students feel confident and prepared, from day one to graduation. The company provides a free and subscription online learning platform that empowers students and educators to succeed through unlocked study tools, documents, and resources. It also offers free and subscription membership that includes access to practice problems, study guides, videos, class notes, and step-by-step explanations for every subject that students study, from economics to literature, biology to history, and accounting to psychology. In 2016, Andrew Grauer, Gregor Carrigan, and Jared Grauer established Course Hero in Redwood City, California.

ROKT

Series E in 2021
Rokt is the global leader in e-commerce technology, powering the Transaction Moment™ of best-in-class companies including Live Nation, Groupon, Staples, Lands' End, Fanatics, GoDaddy, Vistaprint, and HelloFresh. Rokt's mission: To make e-commerce smarter, faster, and better. Through its proprietary technology, Rokt enables its e-commerce clients to increase brand engagement and unlock new revenues in the Transaction Moment™, allowing them to stay ahead of their competition while delivering a superior and individualized experience for each customer. Founded in Sydney, the company now operates in the US, Canada, the UK, Ireland, France, Germany, the Netherlands, Denmark, Sweden, Norway, Finland, Spain, Australia, New Zealand, Singapore, and Japan. Learn more at rokt.com.

Swiggy

Series J in 2021
Swiggy provides a complete food ordering and delivery solution from the best neighborhood restaurants to the urban foodie. Swiggy aims to stand out by offering a more curated list of restaurants and services, not to mention its own in-house delivery fleet that pick up orders from restaurants and deliver it to the customers. It charges between 15-40 percent in commission to restaurants and for smaller orders, customers pay an additional delivery charge between 20 and 50 rupees depending on their city. Currently, Swiggy is in eight cities where it has more than 9,000 restaurants on its platform.

Hyzon Motors

Post in 2021
HYZON Motors Inc manufactures hydrogen-powered trucks and buses. It offers city and coach buses, medium duty trucks, and heavy duty trucks. The company was founded in 2020 and is based in Honeoye Falls, New York.

Harry's, Inc.

Series C in 2015
Harry is a developer of an online platform used to sell shaving equipment and accessories for men. It designs and manufactures its own line of razors and replacement blades, as well as other shaving consumables, and offers its products a-la-carte via its online store or through a subscription model that enables consumers to meet their grooming essentials need online. The company was founded in 2013 and is headquartered in New York.

Faire Wholesale, Inc.

Series G in 2021
Faire Wholesale, Inc. develops and operates an online marketplace which connects independent retailers with manufacturers of the products. It offers Indigo Fair, a wholesale marketplace that enables retailers to browse items from various makers, place wholesale orders, and track shipments online. Faire Wholesale, Inc. was founded in 2016 and is based in San Francisco, California with an additional office in Kitchener, Canada.

Novellusdx Ltd.

Series C in 2020
Novellusdx develops tumor specific driver mutations. It focuses on testing targeted therapy drugs on emulated tumors and quantifying their therapeutic effect, monitoring the oncogenic activity of the patient's relevant genes and proteins, and monitoring the oncogenic activity before and after drug administration. Novellusdx develops assays that detect disregulated translocation of mutated signaling proteins to the nucleus; and measures the impact of a drug or drug candidate on a specific tumor, specifically in terms of its ability to inhibit the up-regulated signaling protein translocation to the nucleus. Haim Gil-ad and Yoram Altschuler founded it on May 1, 2011, with its headquarters in Jerusalem in Israel.

Design Therapeutics

Series B in 2021
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich’s ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Solana Beach, California.

Ventyx Biosciences, Inc.

Series B in 2021
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets.

Civitas Therapeutics

Series C in 2014
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies. The Company develops therapeutics for the treatment of central nervous system and respiratory disorders. It serves patients throughout the United States.

Strata Oncology, Inc.

Series C in 2021
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

MarkForged, Inc.

Post in 2021
MarkForged, Inc. designs, develops, and manufactures 3D printers. Its products include carbon fiber, metal, fiberglass, nylon, and PLA filament 3D printers. The company's printers can print parts, tooling, and fixtures. It also develops EIGER, a 3D printing software. The company was incorporated in 2013 and is based in Cambridge, Massachusetts with European headquarters in Dublin, Ireland.

IronSource

Post in 2021
Working with the world’s largest mobile game companies, ironSource is developing the industry's leading growth engine for games. With a robust mobile ad mediation platform, mobile ad network, and a data-driven user acquisition platform, ironSource closes the monetization and marketing loop to empower game developers to turn their games into successful businesses.

Lucid Motors Inc.

Post in 2021
Lucid Motors sets out to create a car that elevates the human experience and transcends the perceived limitations of space, performance, and intelligence. A car that is intuitive, liberating, and designed for all the ways people get around. Lucid Motors plans to lead in this new era of mobility by returning to the fundamentals of great design – where every decision we make is in service of the individual. Because when you are no longer bound by convention, you are free to define your own path.

WeWork India

Series A in 2017
The We Company is a platform for creators that transforms buildings into dynamic environments for creativity, focus, and collaboration. The company transform buildings into beautiful, collaborative workspaces and provide infrastructure, services, events, and tech so their members can focus on doing what they love. The We Company is formerly known as "WeWork". It was established in 2018 and is headquartered in New York.

Blackbuck

Series E in 2021
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.

Novellus

Series C in 2020
Novellus is a biotechnology company working to develop engineered cellular medicines. The company uses its non-immunogenic mRNA molecules to reprogram and gene-edit cells safely, and with high efficiency. They engineer precision medicines for patient segments and select from its technology toolbox for in vivo, ex vivo, allogeneic and autologous delivery. Novellus platform enables the high-level expression of gene-editing and cell-reprogramming proteins for high-specificity gene repair and both autologous and allogeneic cell therapies. The company is advancing its lead program, a breakthrough therapy for a rare dermatologic disease, through pre-clinical studies. Novellus was founded in 2015 and is headquartered in Cambridge, Massachusetts, United States.

Gemini Therapeutics

Post in 2021
Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.Their therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. Launched with funding from leading life science investors and powered by academic partnerships around the world,they are developing a series of potentially first-in-class therapeutics.

Houzz

Series E in 2017
Houzz is the leading platform for home remodeling and design, providing people with everything they need to improve their homes from start to finish – online or from a mobile device. From decorating a small room to building a custom home and everything in between, Houzz connects millions of homeowners, home design enthusiasts and home improvement professionals across the country and around the world. With the largest residential design database in the world and a vibrant community empowered by technology, Houzz is the easiest way for people to find inspiration, get advice, buy products and hire the professionals they need to help turn their ideas into reality. Headquartered in Palo Alto, CA, Houzz also has international offices in London, Berlin, Sydney, Moscow, Bangalore, Tel Aviv and Tokyo.

Lordstown Motors

Post in 2020
Lordstown Motors Corporation is an American automobile manufacturer of electric vehicles.Lordstown Motors is completing the engineering and development of the first full-electric pickup truck.

RayzeBio

Series D in 2022
RayzeBio, Inc. is a biotechnology company that develops tumor-targeted small molecule medicines that harness the power of radioisotopes. The company provides macrocyclic peptide mimetic binders to deliver therapeutic radioisotopes, such as Actinium-225, an alpha-emitter for solid tumors. RayzeBio, Inc. was founded in 2020 and is based in San Diego, California.

Faire Wholesale, Inc.

Series F in 2021
Faire Wholesale, Inc. develops and operates an online marketplace which connects independent retailers with manufacturers of the products. It offers Indigo Fair, a wholesale marketplace that enables retailers to browse items from various makers, place wholesale orders, and track shipments online. Faire Wholesale, Inc. was founded in 2016 and is based in San Francisco, California with an additional office in Kitchener, Canada.

Nuvalent

Series B in 2021
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. It is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. It was founded in 2017 and is based in Cambridge, Massachusetts.

Kala Pharmaceuticals

Series C in 2016
Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient friendly format. The company's research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept, while establishing R&D collaborations with select partners to improve products in their pipelines.

Trove

Series D in 2021
Trove builds technology that allows brands to take control of their resale marketplaces, deepening customer loyalty and generating new profits. The company provides white-label technology and end-to-end operations that power circular shopping for premium and luxury brands such as Levi’s, Patagonia, REI, Eileen Fisher and Arc’teryx. Trove enables brands to take back items from customers’ closets while maintaining control of their brand equity and owning their customer experience, data and relationships. Rooted in a commitment to sustainability, Trove aims to create a world where all consumers have access to better products with less waste.
Greenlight Financial Technology is a financial services company that specializes in the fields of debit cards for kids and mobile apps. It empowers parents with convenient controls to safely manage family finances and create teachable moments around earning, spending, saving, and giving. Using its patent-pending technology, they can even specify the exact stores in their town or neighborhood where each child's Greenlight card is accepted. The company was founded in 2014 and is headquartered in Atlanta, Georgia.

Scribe Therapeutics

Series B in 2021
Scribe Therapeutics Inc. engages in the engineering, delivery, and development of in vivo therapies and CRISPR molecules to rewrite and repair the underlying cause of genetic disorders. Its technology includes X-Editing (XE), an engineered molecule for therapeutic use and in vivo genetic modification. The company was incorporated in 2017 and is based in Berkeley, California.

Jounce Therapeutics, Inc.

Series B in 2015
Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patients’ quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.

Ventyx Biosciences, Inc.

Venture Round in 2021
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets.

Snapdocs

Series D in 2021
Snapdocs is a mortgage technology company that helps real estate participants closing work together through integration and automation. It also simplifies mortgage loan closings and enhances the borrower experience. The company helps lenders, title, and escrow companies, signing services, and notary publics collaborate to deliver the best signing experience to consumers. Snapdocs suite of business management tools enables mortgage providers to streamline their operations to be compliant and efficient, reduce errors and increase transparency. It was founded in 2012 and is headquartered in San Francisco, California, USA.

Paidy

Series D in 2021
Paidy is a platform for consumers to pay at online stores using only their name and email address. It is optimized for mobile and instant-checkout, Paidy allows consumers to buy online and does not require a credit card or pre-registration. Paidy's payment service allows users to make purchases online, and then pay for them each month in a consolidated bill. The company uses proprietary technology to score creditworthiness, underwrite transactions and guarantee payment to merchants. Since many Japanese consumers prefer not to use credit cards for online payments, Paidy’s service can help vendors increase their conversion rates, average order values and repeat purchases.

Entrada Therapeutics

Series B in 2021
Entrada Therapeutics, Inc., a biotechnology company, engages in the treatment of diseases through the intracellular delivery of biologic. The company enables intracellular delivery of proteins, peptides, and nucleic acids and allows development of programs across intracellular target classes. Its Intracellular enzyme replacement therapy (IC-ERT) is a medical treatment that corrects an enzyme deficiency in the cell, Protein-Protein Interaction Inhibitors. The company was founded in 2016 and is based in Boston, Massachusetts.

Zuora

Series F in 2015
Zuora provides cloud-based software on a subscription basis that enables companies in various industries to launch, manage, and transform into a subscription business. The firm offers Zuora Central platform that acts as an intelligent subscription management hub that automates the subscription order-to-cash process, including quoting, billing, collections, analytics, and revenue recognition. Its products include Zuora Billing, Zuora RevPro, Zuora CPQ, Zuora Insights, and Zuora Collect. Zuora caters to various industries comprising software, hardware, media, transportation, construction, healthcare, education, retail, Internet of Things, and others worldwide. It was founded in 2007 and headquartered in San Mateo, California.

Neon Therapeutics

Series B in 2017
Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead program is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of metastatic or locally advanced, ER-positive, and human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Scorpion Therapeutics, Inc., a biotechnology company, develops next-generation precision oncology technologies for the treatment of cancer. The company develops precision oncology drugs in three areas, including therapies against known oncogenes; agents for known but currently undruggable cancer targets; and drugs for new targets. Scorpion Therapeutics, Inc. was founded in 2020 and is based in Boston, Massachusetts.

Payfone

Series G in 2019
Payfone provides businesses with Identity Certainty - the ability to confirm that their customers are who they say they are to create easy, secure and frictionless experiences across PCs, mobile phones and tablets. They do for digital security what Uber does for hailing taxis and what Amazon does for online shopping. They make authenticating your customers easy for you and effortless for them. They're backed by leading banks, venture firms and wireless carriers, and are based in New York City.

Affirm, Inc.

Series G in 2020
Affirm, Inc. provides Buy with Affirm, a closed-end installment loan product through a platform. The company’s product allows users to buy goods and services offered by online merchants and pay off those purchase in fixed monthly payments. Its users can select Affirm as their payment method at checkout, fill out fields for real-time decision, chose the payment plan that fits their budget, and process their order. Affirm, Inc. was incorporated in 2012 and is based in San Francisco, California with an additional office in Chicago, Illinois.

Redfin

Series G in 2014
Redfin is a provider of real estate search and brokerage services through a combination of real estate web platforms accessible to agents. It represents people buying and selling homes and features all of the broker-listed homes for sale, as well as for-sale-by-owner properties. Its real estate agents work with the company's team of engineers to create tools that make the buying and selling process easier. On their site, Redfin combines MLS listing information with historical data into a single map. Customers can search for homes by neighborhood, city, zip code, MLS number or school zone, and can refine results using detailed parameters like price and number of beds or baths. The company was founded in 2004 by David Eraker, Michael Dougherty, and Dave Selinger, and is based in Seattle, Washington.

Oscar Insurance

Series C in 2015
Oscar Garden State Insurance Corporation provides health insurance services. The company also develops software, which provides health care services to the users. The application allows finding doctors according to the location and ratings. The company offers services in New York, Texas, California, New Jersey, Ohio, and Tennessee, United States. Oscar Garden State Insurance Corporation was founded in 2017 and is headquartered in New York, New York. Oscar Garden State Insurance Corporation operates as a subsidiary of Mulberry Health, Inc.

Coinbase Support

Series E in 2018
Coinbase is an online platform that allows merchants, consumers, and traders to transact with digital currency. It allows its users to create their own bitcoin wallets and start buying or selling bitcoins by connecting with their bank accounts. In addition, it provides a series of merchant payment processing systems and tools that support many highly-trafficked websites on the internet. Coinbase was launched in 2012 with a mission to create an open financial system for the world. It is operated from San Francisco, California.

Policybazaar

Series E in 2017
Policybazaar Insurance Brokers Private Limited develops a software which offers insurance services. The company’s services include life insurance, health insurance, car insurance, two wheeler insurance, and other insurance including general insurance, travel insurance, and home insurance. The company, formerly known as Policybazaar Insurance Web Aggregator Private Limited, was founded in 2014 and is based in Gurugram, India.
NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.

Swiggy

Series J in 2021
Swiggy provides a complete food ordering and delivery solution from the best neighborhood restaurants to the urban foodie. Swiggy aims to stand out by offering a more curated list of restaurants and services, not to mention its own in-house delivery fleet that pick up orders from restaurants and deliver it to the customers. It charges between 15-40 percent in commission to restaurants and for smaller orders, customers pay an additional delivery charge between 20 and 50 rupees depending on their city. Currently, Swiggy is in eight cities where it has more than 9,000 restaurants on its platform.

Verve Therapeutics

Series B in 2021
Verve Therapeutics, Inc. develops therapies for editing the adult human genomes. It utilizes human genetic analysis and gene-editing technology for developing therapies to reduce the risk of coronary artery diseases. The company serves the biotechnology and health care sectors. It has a strategic alliance with Beam Therapeutics for developing delivery technologies against cardiovascular targets; and Verily, for the development of gene editing delivery vehicles. Verve Therapeutics, Inc. was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in September 2019. The company was founded in 2018 and is based in Cambridge, Massachusetts with a research facility in Philadelphia, Pennsylvania.

E-scape Bio

Venture Round in 2020
E-Scape Bio, Inc., a biopharmaceutical company, discovers and develops small molecule therapies to treat genetically defined subpopulations in neurodegenerative diseases. Its programs improve the lives of patients suffering from Alzheimer’s disease, Parkinson’s disease, and sphingolipid storage disorders. E-Scape Bio, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Swiggy

Series I in 2020
Swiggy provides a complete food ordering and delivery solution from the best neighborhood restaurants to the urban foodie. Swiggy aims to stand out by offering a more curated list of restaurants and services, not to mention its own in-house delivery fleet that pick up orders from restaurants and deliver it to the customers. It charges between 15-40 percent in commission to restaurants and for smaller orders, customers pay an additional delivery charge between 20 and 50 rupees depending on their city. Currently, Swiggy is in eight cities where it has more than 9,000 restaurants on its platform.

Generation Bio Co.

Series C in 2020
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.

General Assembly

Series D in 2015
General Assembly provides education and career transformation, specializing in today’s most in-demand skills. The leading source for training, staffing, and career transitions, we foster a flourishing community of professionals pursuing careers they love. It was founded in 2011 and headquartered in New York, United States.

HeartFlow

Series E in 2017
HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease. It offers HeartFlow Analysis, a non-invasive solution available in the United States, Europe, and Japan that helps a physician evaluate whether a patient has significant coronary artery disease based on anatomy and physiology. The company was started in 2007 and is based in Redwood City, California.

PPRO Group

Private Equity Round in 2021
PPRO provides access, processing, and collection services for alternative payment methods and value added services. Founded in 2006, their vision from the start has been to simplify access to the many different payment methods required by consumers and businesses across the world. Today they offer a full range of flexible services for payment industry leaders as well as e-money issuing programs for consumers and corporate. Headquartered in the UK, we’re FCA licensed to issue e-money, are principal members of Mastercard and VISA and continue to strengthen their links with alternative payment method schemes and banks around the world.

Lookout, Inc.

Series F in 2014
Lookout is a cybersecurity company that predicts and stops mobile attacks before harm is done to an individual or an enterprise. Lookout’s cloud-based technology is fueled by a global sensor network of more than 60 million users and tens of thousands of apps that are added daily. With this dataset of virtually all the mobile code in the world and the predictive machine intelligence to analyze and make sense of the data, Lookout can identify connections that would otherwise go unseen and stop cybercriminals from attacking mobile devices. Headquartered in San Francisco, Lookout has offices in Boston, London, Singapore, Tokyo, Toronto and Washington, D.C.

ezCater

Series D in 2018
ezCater, Inc. provides online catering ordering solutions for small start-ups and Fortune 500 companies. Its solutions enable users to order food online for meetings. The company offers ezManage, a catering management platform; and ezOrdering that provides restaurants with means to accept online catering orders on their own website. ezCater, Inc. was founded in 2007 and is based in Boston, Massachusetts. It has an additional office in Denver, Colorado.
Juspay is a developer of an online platform designed to be used for mobile-based payments. The company's online platform is a SaaS layer on top of payment gateways to simplify integration, improve robustness and ease the management of diverse and rapidly evolving payment options, enabling users to make electronic transactions securely and efficiently.

neoSaej

Venture Round in 2009
neoSaej's first product is MoneyAisle, a next generation online auction marketplace. Unlike the seller-centric auctions popularized by eBay, MoneyAisle's auctions are buyer-centric: many sellers bid live to win each customer's business. Buyers benefit through great deals by having sellers actively compete for their business in free, safe, instantaneous auctions, on demand, 24/7.

ACV Auctions

Series E in 2019
ACV Auctions, Inc., a wholesale automotive auction company, operates a mobile platform that enables used-car dealers to view, bid, and purchase car inventory via online auctions. Its dealer-to-dealer and online automotive marketplace allows used car dealers to select the type of cars they wish to purchase; companies to send an alert to the dealer’s mobile device when vehicles become available; and dealers to follow live auctions. ACV Auctions, Inc. was founded in 2014 and is based in Buffalo, New York.

Compass

Series E in 2017
Compass operates as a real estate brokerage company. It also provides a real estate listing app for iOS and Android that helps in buying, selling, and renting homes in the United States. Ori Allon, Robet Reffkin, and Ugo Di Girolamo founded Urban Compass on October 4, 2012, that became Compass in February 2015. Its headquarters is in New York City with additional offices in the United States.

Mozido

Series B in 2014
Mozido operates a cloud-based mobile payments platform. It delivers payments and mLoyalty solutions to financial institutions, MNOs, restaurants, municipalities, mobile telecom providers, and consumer packaged goods companies as well as companies in retail, hospitality, and government industries that serve banked and unbanked consumers via the mobile phone. Mozido's products include mobile and Web payments, a customer engagement solution, mobile rewards, mVault, a real-time, B2B payment processing platform that addresses and replaces the current cash process, and MoTEAF, a cloud-based, mobile ecosystem that acts as a point of integration, allowing clients to pay, engage, and reward through the mobile channel. Michael A. Liberty founded it in 2008, with its headquarters in Austin in Texas and operations in the United States, Mexico, Central America, the Caribbean, the Middle East, Southeast Asia, and Africa.

The Trade Desk

Series C in 2016
The Trade Desk is a technology company that empowers buyers of advertising. The Trade Desk provides a self-service platform that enables ad buyers to manage data-driven digital advertising campaigns using their own teams across various advertising formats, including display, video, and social, and on a multitude of devices, including computers, mobile devices, and connected TV. Headquartered in Ventura, Calif., The Trade Desk has offices across the United States, Europe, and Asia.

Slack Fund

Series H in 2018
Slack Technologies, Inc. operates Slack, a business technology software platform in the United States and internationally. Its platform brings together people, applications, and data, as well as sells its offering under a software-as-a-service model. The company was formerly known as Tiny Speck, Inc. and changed its name to Slack Technologies, Inc. in 2014. Slack Technologies, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

DataLogix

Series C in 2014
Datalogix® is the industry-recognized leader at connecting digital media and offline purchasing data. We help more than half of the top 100 consumer marketers increase the effectiveness and measurability of their advertising. DLX Platform®, encompasses over $1 trillion in consumer spending and powers campaigns for more than 75% of online media companies. DLX ROI® is rapidly becoming the industry standard for measuring offline sales lift for digital media. Datalogix also offers predictive analytics for Direct Mail, and integrated media solutions via the DLX Net. Our expertise spans the major consumer segments, including Retail, CPG, Automotive, Telecom, Travel and Financial Services. We are based in Colorado, with offices in New York City, San Francisco, Boston, Chicago, Detroit, and London.

Affirm, Inc.

Series F in 2019
Affirm, Inc. provides Buy with Affirm, a closed-end installment loan product through a platform. The company’s product allows users to buy goods and services offered by online merchants and pay off those purchase in fixed monthly payments. Its users can select Affirm as their payment method at checkout, fill out fields for real-time decision, chose the payment plan that fits their budget, and process their order. Affirm, Inc. was incorporated in 2012 and is based in San Francisco, California with an additional office in Chicago, Illinois.

Omada Health

Series D in 2019
Omada Health, Inc. designs and develops online digital healthcare programs that coordinate with the patients in chronic condition. Its programs help employers and health planers to identify the people within their population at risk for developing preventable chronic conditions, such as prediabetes, diabetes, hypertension, and heart diseases. Omada Health, Inc. was incorporated in 2011 and is based in San Francisco, California with an additional office in Atlanta, Georgia.

Centessa Pharmaceuticals

Series A in 2021
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
Black Diamond Therapeutics, Inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. The company is also developing allosteric-EGFR mutation inhibitors; and various early stage pipeline programs targeting allosteric mutations in kinases related to cancer and/or rare genetic diseases. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Malauzai Software, Inc.

Series C in 2014
Malauzai was incorporated in 2009 in response to the growing demand for a technology company that could provide innovative mobile solutions for community financial organizations. As a cool company in a cool town with a focus primarily on community financial institutions, Malauzai provides Consumer, Small Business, Employee SmartApps, SmartwebApps and SmartwearApps that enhance the customer experience for mobile and Internet banking, ultimately resulting in increased value for financial institutions.
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a novel therapeutic product for the acute treatment of migraine. Its lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in Phase III clinical trials and can be self-administered with a proprietary pre-filled, single-use, and nasal delivery device. The company was founded in 2016 and is headquartered in South San Francisco, California.

nCino, Inc.

Series B in 2014
NCino offers a cloud-based bank operating system created by bankers for bankers. The system helps increase profitability, productivity gains, regulatory compliance, and operational transparency at all organizational levels as well as across all lines of business. Following a process structure similar to a bank’s loan accounting system, the bank operating system offers combined services through its business process management, loan lifecycle, business intelligence, and document management solutions.

Optical Switch

Venture Round in 2000
Optical Switch Corporation is a manufacturer of optical switches and automated lithography tool systems.
Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. The company’s initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich’s ataxia. Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass.

DocuSign

Series F in 2015
DocuSign, Inc. provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals. The company was 2003 and is headquartered in San Francisco, California.

Airbnb, Inc.

Series E in 2015
Airbnb, Inc. operates a platform for stays and experiences to guests worldwide. The company’s marketplace model connects hosts and guests online or through mobile devices to book spaces and experiences. It primarily offers private rooms and luxury villas. The company was formerly known as AirBed & Breakfast, Inc. and changed its name to Airbnb, Inc. in November 2010. Airbnb, Inc. was founded in 2007 and is headquartered in San Francisco, California.

Peloton Interactive, Inc.

Series E in 2017
Peloton is revolutionizing the fitness industry by merging high-design with modern technology to provide access to live and on-demand fitness group classes led by elite NYC instructors. With instant access to classes, performance tracking metrics and a motivating real-time leaderboard, Peloton is changing the way people get fit through a comprehensive and socially connected-experience that makes every workout both efficient and addicting. By merging hardware, software, and content, Peloton creates the most unique, efficient and addicting workout experience on the market. Peloton is sold online and in their growing number of showrooms across the country.

Allena Pharmaceuticals

Series C in 2015
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Coupang

Private Equity Round in 2014
Coupang Corp. owns and operates an online retailing platform that provides daily discounted deals for goods and services. The company provides its platform through mobile application. It offers merchandise, including baby goods, fashion, beauty products, food, home goods and decor, books, toys, sporting goods, electronics, car accessories, pet supplies, stationery, health food and tickets for travel and events. The company was founded in 2010 and is headquartered in Seoul, South Korea with additional offices in Beijing, China; Shanghai, China; Los Angeles, California; Seattle, Washington. Coupang Corp. operates as a subsidiary of Coupang USA, Inc.

New Relic

Private Equity Round in 2014
New Relic is a digital intelligence company that delivers full-stack visibility and analytics with more than 14,000 paid business accounts. The New Relic digital intelligence platform provides actionable insights to drive digital business results. The company was founded in 2008 and is headquartered in San Francisco, California.

LianBio

Venture Round in 2020
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics.

Rhythm Metabolic

Series A in 2015
Rhythm Metabolic is the subsidiary of Rhythm Pharmaceuticals that develops setmelanotide (RM-493), a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies in the MC4 pathway. It was established in 2013 and is headquartered in Boston, Massachusetts.

Compass

Series D in 2016
Compass operates as a real estate brokerage company. It also provides a real estate listing app for iOS and Android that helps in buying, selling, and renting homes in the United States. Ori Allon, Robet Reffkin, and Ugo Di Girolamo founded Urban Compass on October 4, 2012, that became Compass in February 2015. Its headquarters is in New York City with additional offices in the United States.

Uber Technologies, Inc.

Series D in 2014
Uber is evolving the way the world moves. By seamlessly connecting riders to drivers through our app, we make cities more accessible, opening up more possibilities for riders and more business for drivers. From our founding in 2009 to our launches in over 300 cities today, Uber's rapidly expanding global presence continues to bring people and their cities closer.

Nuvation Bio

Post in 2020
Nuvation Bio Inc., a biopharmaceutical company, focuses on the development of therapies for oncology. Its portfolio includes various oncology programs with multiple drug development candidates. Nuvation Bio Inc.was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. The company was founded in 2018 and is based in New York, New York with an additional office in San Francisco, California.

Payoneer

Series E in 2015
Payoneer empowers global commerce by connecting businesses, professionals, countries and currencies with its innovative cross-border payments platform. In today's borderless digital world, Payoneer enables millions of businesses and professionals from more than 200 countries to reach new audiences by facilitating seamless, cross-border payments. Additionally, thousands of leading corporations including Google, Airbnb, Elance-oDesk and Getty Images rely on Payoneer's mass payout services. With Payoneer's fast, flexible, secure and low-cost solutions, businesses and professionals in both developed and emerging markets can now pay and get paid globally as easily as they do locally. Founded in 2005 and based in New York, Payoneer is venture-backed, profitable and ranked in the top 100 of Inc. 5000's Financial Services companies.

Nivalis Therapeutics

Venture Round in 2014
Nivalis Therapeutics is developing a novel class of disease-modifying therapies that are designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell signaling effects that are implicated in the pathophysiology of cystic fibrosis (CF).The Company’s lead candidate, N91115 initially targets patients with the F508del mutation, the most common disease-causing mutation in CF. Nivalis Therapeutics is dedicated to making a difference in the lives of patients with cystic fibrosis and their families. The company was founded in 2007 and is headquartered in Boulder, Colorado, United States.

Invuity

Private Equity Round in 2015
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Dyne Therapeutics

Series B in 2020
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapies. The company was founded in 2017 and is based in Waltham, Massachusetts.

Klarna

Secondary Market in 2015
Klarna is an eCommerce payment solutions platform for merchants and shoppers. The platform gives customers the freedom to choose how and when to pay. They also offer direct payments, pay after delivery options, and installment plans. Klarna is a regulated bank known for its “buy now, pay later” model that offers shoppers interest-free financing on retail purchases over a period of installments. Klarna was founded in 2005 in Stockholm, Sweden by Sebastian Siemiatkowski, Niklas Adalberth, and Victor Jacobsson.

Powa Technologies

Series A in 2013
Powa Technologies is an international commerce specialist that creates technologies to seamlessly integrate the physical and digital worlds. It offers PowaTag, a mobile application that enables payments, which is comprised of PowaTag codes that transform existing marketing media such as billboards, printed material, and advertisements. It also offers many other products, including PowaWeb, powaPos, PowaPIN, and more. The company was incorporated in 2007 and is based in London, United Kingdom. It operates as a subsidiary of SuperCom Ltd.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead program is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of metastatic or locally advanced, ER-positive, and human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Sharecare

Venture Round in 2015
Sharecare is the digital health company that helps people manage all their health in one place. The Sharecare platform provides each person – no matter where they are in their health journey – with a comprehensive and personalized health profile, where they can dynamically and easily connect to the information, evidence-based programs and health professionals they need to live their healthiest, happiest and most productive life. With award-winning and innovative frictionless technologies, scientifically validated clinical protocols and best-in-class coaching tools, Sharecare helps providers, employers and health plans effectively scale outcomes-based health and wellness solutions across their entire populations. To learn more, visit www.sharecare.com. In 2017 alone, Sharecare has raised more than $100 million in new funding; and more than $300 million in total capital since its founding in 2010. May 26, 2017 Sharecare announced it has received an investment from global alternative investment firm, Summit Partners. Sharecare will use the debt capital to fund new capabilities and acquire talent to support the aggressive growth trajectory of both the company and its platform, where people can manage all their health in one place.

Veracode, Inc.

Series F in 2014
Veracode is the only independent provider of cloud-based application intelligence and security verification services. The Veracode platform provides the fastest, most comprehensive solution to improve the security of internally developed, purchased, or outsourced software applications and third-party components. It was founded in 2006 and headquartered in Burlington, Massachusetts.

Attentive Mobile, Inc.

Series D in 2020
Attentive Mobile, Inc. develops a personalized mobile messaging platform for companies to acquire, retain, and interact with mobile audiences. It offers brands to automatically send personalized mobile messages across the customer lifecycle ranging from product recommendations and limited time sales to payments and real time customer service. The company serves e-commerce, retail, food and beverage, travel and hospitality, entertainment, media and publishing, education, and non-profit industries Attentive Mobile, Inc. was formerly known as Franklin Mobile Inc. The company was founded in 2016 and is based in New York, New York.

UNUM Therapeutics

Series B in 2015
Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy. Unum is seeking partners interested in using the ACTR technology to arm proprietary tumor-specific antibodies with a T-cell to improve their therapeutic potential. The company is headquartered in Cambridge, MA.

The Honest Company, Inc.

Series C in 2014
The Honest Company creates eco-friendly, convenient, and affordable products for babies and homes. Its products include eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products all packed in convenient bundles that can be customized, personalized, and conveniently shipped whenever needed. The company was founded in 2011 and headquartered in California, United States.

Nanigans

Series B in 2015
Nanigans provides an advertising automation software that powers the in-house performance marketing teams. Offered as Software-as-a-Service, Nanigans software features programmatic media buying, predictive revenue optimization, and real-time business intelligence across today’s most valuable channels. Nanigans is headquartered in Boston, with offices in New York, San Francisco, Seattle, London, Sydney, and Singapore.

SoFi

Series D in 2015
SoFi is a finance company that offers a range of lending and wealth management services. The company primarily caters to early-stage professionals and offers variable and fixed rate parent, personal, and MBA loans, mortgage refinancing, and more. They create modern financial products and services that help people borrow, save, spend, invest, and protect their money better so that they can achieve financial independence and realize their ambitions from owning a home to saving for retirement, paying off their student loans, and more. It was founded in 2016 and is headquartered in San Francisco, California.

Speakaboos

Series B in 2016
BEGiN is the award-winning education technology company that creates engaging and effective learning products to bring the highest quality education to young children everywhere. Their library of interactive stories helps their child fall in love with reading while building critical skills. BEGiN’s investors and partners include some of the most recognized and well-loved children’s brands including Sesame Workshop, LEGO Ventures, Gymboree Play and Music, and Fisher-Price. BEGiN was co-founded by Neal Shenoy, Noelle Millholt, and Stephanie Dua and is one of Crain’s 100 Best Places to Work in New York City.

Scopely

Series E in 2020
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

nCino, Inc.

Series B in 2015
NCino offers a cloud-based bank operating system created by bankers for bankers. The system helps increase profitability, productivity gains, regulatory compliance, and operational transparency at all organizational levels as well as across all lines of business. Following a process structure similar to a bank’s loan accounting system, the bank operating system offers combined services through its business process management, loan lifecycle, business intelligence, and document management solutions.

Away

Series D in 2019
Away is a modern travel and lifestyle brand. The company is a vertically-integrated company offering beautiful, high-quality luggage at an affordable price point. Away designs special objects for modern travel. It started with luggage, designed with thoughtful features that solve real travel problems—for life. Now all that’s left is the world in front of you and the people you share it with. Because getting Away means getting more out of every trip to come.

Neon Therapeutics

Series B in 2017
Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.

FORMA Therapeutics, Inc.

Series D in 2019
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing FT-2102, an oral selective small molecule investigational agent that is designed to bind to and inhibit mutated IDH1 enzymes, which is being evaluated in a Phase 2 trial for relapsed/refractory AML, as well as an exploratory Phase 1 trial for glioma; and FT-4101 and FT-8225, which are selective fatty acid synthase inhibitors. The company was founded in 2007 and is headquartered in Watertown, Massachusetts.

Forty Seven

Series B in 2017
Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven's lead program, 5F9, is a monoclonal antibody against the CD47 receptor, a "don't eat me" signal that cancer cells commandeer to avoid being ingested by macrophages. This antibody is currently being evaluated in six clinical studies in patients with solid tumors, acute myeloid leukemia, non-Hodgkin's lymphoma and colorectal carcinoma.

Verve Therapeutics

Series A in 2020
Verve Therapeutics, Inc. develops therapies for editing the adult human genomes. It utilizes human genetic analysis and gene-editing technology for developing therapies to reduce the risk of coronary artery diseases. The company serves the biotechnology and health care sectors. It has a strategic alliance with Beam Therapeutics for developing delivery technologies against cardiovascular targets; and Verily, for the development of gene editing delivery vehicles. Verve Therapeutics, Inc. was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in September 2019. The company was founded in 2018 and is based in Cambridge, Massachusetts with a research facility in Philadelphia, Pennsylvania.

Arcus Biosciences, Inc.

Series C in 2017
Arcus Biosciences is biotech company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. Arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the San Francisco bay area, in the heart of the world’s largest biotechnology research hub.

Current

Series C in 2020
Current is a leading U.S. challenger bank built to meet the needs of people with unique lives who have been overlooked by the traditional banking industry. Our proprietary Current Core technology allows us to provide premium banking services for everyone, regardless of age or income, and improve the financial outcomes of our members without overdraft fees, minimum balance requirements, or hidden fees. We give members up to two days faster direct deposit paychecks, free overdrafts up to $100 with Overdrive™ , points on purchases redeemable for cash back, access to 55,000 free ATMs worldwide as well as 24/7 member support 365 days a year.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.
Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat. Founded in 2011 by a proven team of scientists and entrepreneurs with world-renowned expertise in the development of targeted cancer therapies, cancer genomics, and rational drug development, Blueprint Medicines is poised to realize the promise of the cancer data revolution: truly personalized therapies that improve outcomes and shift cancer to a manageable condition.

ForeScout Technologies

Series G in 2016
ForeScout is transforming security through visibility. We help make the invisible visible by providing Global 2000 enterprises and government agencies with agentless visibility and control of traditional and IoT devices the instant they connect to the network. Our technology integrates with disparate security tools to help organizations accelerate incident response, break down silos, automate workflows and optimize existing investments.

Freeline Therapeutics

Series C in 2020
Freeline Therapeutics is a biotechnology company that develops liver directed gene therapies for bleeding disorders and other diseases. Its therapies are based on next-generation proprietary AAV vector platform, with its lead program being a gene therapy to treat haemophilia B.

Creditas

Series E in 2020
Creditas is a financial technology company, operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

Nurix

Venture Round in 2020
Nurix develops small molecule inhibitors for the treatment of proliferative and degenerative diseases. The company’s product engine leverages a deep mechanistic understanding of the UPS to deliver effective small molecule drug candidates with the potential to make a dramatic difference for patients. Nurix drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. The company discovers drugs that harness the body's natural process to control protein levels. Their focus is on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents. Nurix was founded in 2009 by internationally recognized experts in the ubiquitin-proteasome field and is funded by leading life science investors, Third Rock Ventures, and The Column Group. The company is headquartered in San Francisco, California.

Pure Storage, Inc.

Series F in 2014
Pure Storage is pioneering a new class of enterprise storage that has been designed from the ground up to take full advantage of flash memory. The company's products accelerate random I/O-intensive applications like server virtualization, desktop virtualization (VDI), database (OLTP, rich analytics/OLAP, SQL, NoSQL), and cloud computing. Pure Storage makes it cost effective to broadly deploy flash within the data center, enabling organizations to manage growth within existing power and space constraints. Launching later this year, the company's products are in private beta with select customers. Pure Storage is funded by Greylock Partners and Sutter Hill Ventures.

Edgewise Therapeutics

Series C in 2020
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.

Atreca

Series B in 2017
Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.

Tricida, Inc.

Series D in 2017
Tricida, Inc. is a late-stage pharmaceutical company focused on the development and commercialization of its lead product candidate, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Metabolic acidosis has been associated with increased muscle wasting, loss of bone density and death.

Synthego

Series D in 2020
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs. By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology. The company was founded in 2012 and is based in Redwood City, California.

Sprinklr Inc.

Series F in 2016
Sprinklr is a provider of enterprise software for customer experience management. Its software aims to help brands understand the conversations that matter most on channels such as social media, messaging, blogs, and review sites. Companies like Microsoft and McDonald's rely on Sprinklr to help them manage social media marketing, advertising, research, customer care, and engagement by using the company's products in one Modern CXM platform which is the Modern Marketing, Modern Advertising, Modern Research, Modern Care, and Modern Engagement. The insights Sprinklr uncovers from public conversations and comments help brands catch a crisis before it goes viral, develop new products, optimize creative content, and reduces customer care costs. The company was founded in 2009 by Ragy Thomas in New York.

Patreon

Series E in 2020
Patreon Inc. operates a platform for enabling content creators and artists to be able to fund their work. It offers Patreon.com, a communications platform for enabling connections between users and makes them accessible various content, including videos, photographs, images, artwork, graphics, audio clips, comments, data, text, software, scripts, projects, other material and information, and associated trademarks and copyrightable works. The company was founded in 2013 and is based in San Francisco, California.

VelosBio, Inc.

Series B in 2020
VelosBio, Inc., a biopharmaceutical company, develops novel antibody-drug conjugates (ADCs) to treat hematological cancers and solid tumors. The company develops cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1). Its portfolio includes VLS-101, a ROR1-directed antibody-drug conjugate for patients with hematologic and solid tumor malignancies. The company was incorporated in 2017 and is headquartered in San Diego, California. As of December 18, 2020, VelosBio, Inc. operates as a subsidiary of Merck & Co., Inc.

Global Blood Therapeutics

Series B in 2015
GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. It was founded in 2012 and headquartered in San Francisco, California.

TabbedOut

Series C in 2015
TabbedOut puts you in control of your tab at bars and restaurants. Say goodbye to end-of-night bar lines, and flagging down your server when you’re ready to settle the bill. Never leave your card at the bar again! TabbedOut is easier and more secure than handing over your credit card to a stranger. Open a tab, view the running total, and pay for it instantly (and securely) all from your phone. You can even split your tab among friends, post to Facebook or Twitter to let your friends know where you’re dining, send a positive or negative review of your experience, and get offers sent from your favorite venue straight to your phone. TabbedOut takes the hassle out of dining out for good. We are adding new locations every day, so check in often on the locations screen. Don’t see your favorite bar or restaurant on the list? Let us know! Tweet at or Facebook us at @tabbedout. For merchants: TabbedOut is the premier marketing and analytics platform built exclusively for the hospitality industry and powered by mobile payments. We allow our merchants real time insight into their customers through our proprietary software system that tracks spending habits, product preferences, customer feedback and loyalty rewards. Best of all, TabbedOut allows you, the merchant, to accept mobile payments integrated into your POS system. Finally, POS systems and mobile payments meet customer marketing and rewards in real time. That’s the power of TabbedOut! Free to download and no hidden fees.

Pinterest

Series G in 2015
Pinterest, Inc. provides visual discovery engine in the United States and internationally. The company’s engine allows people to find inspiration for their lives, including recipes, home and style ideas, travel destinations, and others. It shows them visual recommendations based on people personal taste and interests. The company was formerly known as Cold Brew Labs Inc. and changed its name to Pinterest, Inc. in April 2012. Pinterest, Inc. was founded in 2008 and is headquartered in San Francisco, California.

Powa Technologies

Series C in 2014
Powa Technologies is an international commerce specialist that creates technologies to seamlessly integrate the physical and digital worlds. It offers PowaTag, a mobile application that enables payments, which is comprised of PowaTag codes that transform existing marketing media such as billboards, printed material, and advertisements. It also offers many other products, including PowaWeb, powaPos, PowaPIN, and more. The company was incorporated in 2007 and is based in London, United Kingdom. It operates as a subsidiary of SuperCom Ltd.

Dataminr

Series D in 2015
Dataminr is an AI platform that detects the earliest signs of high-impact events and emerging risks from publicly available information. It discovers, distills, and delivers alerts from the increasingly diverse and complex landscape of publicly available information including social media, blogs, information sensors, and the dark web, ensuring that businesses have the knowledge they need to act with confidence.

Invitae

Series F in 2014
Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. What’s our plan? It takes three steps: --Make genetic testing more affordable and accessible than ever before. --Build a secure and trusted genome management infrastructure. --Design a new global community for sharing genetic information to advance science and medicine. Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.

PagerDuty

Series D in 2018
PagerDuty is an operations performance platform delivering visibility and actionable intelligence across the entire incident lifecycle. Their SaaS-based solution empowers over 10,000 small, mid-size, and enterprise global customers such as Comcast, eHarmony, Slack, and Lululemon with the insight to intelligently respond to critical disruptions for exceptional customer experience. PagerDuty was founded to deliver a new and innovative approach to increase business response and efficiency. When brand reputation depends on customer satisfaction, PagerDuty arms businesses with the insight to proactively manage incidents and events that may impact customers across their IT environment.

Spark Therapeutics, Inc.

Series B in 2014
Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases. The founding team includes scientists who have led the advancement of gene therapy over the past two decades, establishing human proof of concept of the expression of gene therapy in the eye and liver. Spark’s robust pipeline includes SPK-RPE65, a fully enrolled, pivotal Phase 3 program in blindness due to mutations in the RPE65 gene, SPK-CHM for the treatment of choroideremia, and SPK-FIX, a program for the potential treatment of hemophilia B through a global collaboration with Pfizer Inc., as well as preclinical programs to address neurodegenerative diseases and other retinal degenerative diseases and hematologic disorders. Spark has rights to a proprietary manufacturing platform that has a track record supporting clinical studies across diverse therapeutic areas and routes of administration. Spark’s expertise across research, clinical, regulatory and manufacturing builds on a legacy of innovation and excellence in gene therapy established by Spark’s team while at The Children’s Hospital of Philadelphia Center for Cellular and Molecular Therapeutics.
Artiva Biotherapeutics, Inc., a biotech company, develops and manufactures cellular immunotherapies for cancer patients. The company offers a pipeline of off-the-shelf, allogeneic natural killer (NK) cell therapies for the treatment of hematologic cancers or solid tumors. The company’s products target CD20 and CD19 in B-cell lymphomas and HER2 in various solid tumors. The company was founded in 2019 and is headquartered in San Diego, California. Artiva Biotherapeutics, Inc. operates as a subsidiary of Green Cross Holdings Corporation.

Rethink Robotics

Series D in 2015
Rethink Robotics helps manufacturers meet the challenges of an agile economy with an integrated workforce, combining trainable, safe and cost-effective robots with skilled labor. Its Baxter robot, driven by Intera, an advanced software platform, gives world-class manufacturers and distributors in automotive, plastics, consumer goods, electronics and more, a workforce multiplier that optimizes labor. With Rethink Robotics, manufacturers increase flexibility, lower costs and can invest in skilled labor—all advantages in fueling continuous innovation and sustainable competitive advantage. Committed to accelerating robotics innovation in manufacturing and beyond, Rethink Robotics’ Baxter Research Robot gives academic and corporate research environments a humanoid robot platform with integrated sensors and an open software development kit for creating custom applications. Based in Boston, Massachusetts, the company is funded by Bezos Expeditions, Charles River Ventures, Highland Capital Partners, Sigma Partners, Draper Fisher Jurvetson, and Two Sigma Ventures.

Goldfinch Bio, Inc.

Series B in 2020
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. It is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease. Its Product Engine will industrialize the integration of genetics and kidney biology and confer a differentiated ability to identify, validate, and pursue novel therapeutic targets to treat progressive kidney disease. The company was founded in 2016 and is based in Cambridge, Massachusetts.

MarkLogic

Series F in 2015
Data integration is one of the most complex IT challenges, and its mission is to simplify it. The MarkLogic Data Hub is a highly differentiated data platform that eliminates friction at every step of the data integration process, enabling organizations to achieve a 360 view faster than ever. By simplifying data integration, MarkLogic helps organizations gain agility, lower IT costs, and safely share their data. Organizations around the world trust MarkLogic to handle their mission-critical data, including 6 of the top 10 banks, 5 of the top 10 pharmaceutical companies, 6 of the top 10 publishers, 9 of the 15 major U.S. government agencies, and many more. Headquartered in Silicon Valley, MarkLogic has offices throughout the U.S., Europe, Asia, and Australia.

The Honest Company, Inc.

Series D in 2015
The Honest Company creates eco-friendly, convenient, and affordable products for babies and homes. Its products include eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products all packed in convenient bundles that can be customized, personalized, and conveniently shipped whenever needed. The company was founded in 2011 and headquartered in California, United States.